1. Home
  2. TRVI vs AHH Comparison

TRVI vs AHH Comparison

Compare TRVI & AHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • AHH
  • Stock Information
  • Founded
  • TRVI 2011
  • AHH 1979
  • Country
  • TRVI United States
  • AHH United States
  • Employees
  • TRVI N/A
  • AHH N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • AHH Real Estate
  • Sector
  • TRVI Health Care
  • AHH Finance
  • Exchange
  • TRVI Nasdaq
  • AHH Nasdaq
  • Market Cap
  • TRVI 725.7M
  • AHH 585.2M
  • IPO Year
  • TRVI 2019
  • AHH 2013
  • Fundamental
  • Price
  • TRVI $8.07
  • AHH $7.40
  • Analyst Decision
  • TRVI Strong Buy
  • AHH Buy
  • Analyst Count
  • TRVI 9
  • AHH 4
  • Target Price
  • TRVI $20.72
  • AHH $8.38
  • AVG Volume (30 Days)
  • TRVI 2.9M
  • AHH 481.7K
  • Earning Date
  • TRVI 11-05-2025
  • AHH 11-03-2025
  • Dividend Yield
  • TRVI N/A
  • AHH 11.10%
  • EPS Growth
  • TRVI N/A
  • AHH N/A
  • EPS
  • TRVI N/A
  • AHH 0.13
  • Revenue
  • TRVI N/A
  • AHH $544,168,000.00
  • Revenue This Year
  • TRVI N/A
  • AHH N/A
  • Revenue Next Year
  • TRVI N/A
  • AHH $4.50
  • P/E Ratio
  • TRVI N/A
  • AHH $57.08
  • Revenue Growth
  • TRVI N/A
  • AHH N/A
  • 52 Week Low
  • TRVI $2.36
  • AHH $6.10
  • 52 Week High
  • TRVI $9.92
  • AHH $12.28
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 53.13
  • AHH 60.88
  • Support Level
  • TRVI $6.93
  • AHH $7.16
  • Resistance Level
  • TRVI $9.92
  • AHH $7.49
  • Average True Range (ATR)
  • TRVI 0.76
  • AHH 0.14
  • MACD
  • TRVI 0.11
  • AHH 0.02
  • Stochastic Oscillator
  • TRVI 37.96
  • AHH 81.25

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.

Share on Social Networks: